Literature DB >> 6990750

The emergence of infection surveillance and control programs in US hospitals: an assessment, 1976.

R W Haley, R H Shachtman.   

Abstract

To assess the current state of hospitals' infection surveillance and control programs (ISCPs) nationwide and to provide a sampling frame for selecting hospitals for later phases of the SENIC Project, the authors mailed a screening questionnaire in March, 1976, to virtually all US hospitals; 86% of those in the SENIC target universe responded. Of these, 64% (2299) reported that their ISCPs were being supervised by a physician or a microbiologist with special interest in infection control, and 42% had an infection control nurse (ICN), or equivalent, working at least half time. In contrast to the supervisors, most of the ICN's had recieved special training in hospital infection epidemiology and spent the majority of their time doing surveillance. Almost all hospitals (87%) had practiced some form of infection surveillance. Almost all hospitals (87%) had practiced some form of infection surveillance, with half reporting very active programs. Larger hospitals with ISCP staff tended to use active clinical casefinding methods, while smaller hospitals tended to use passive techniques. Most hospitals (76%) were collecting relatively large numbers of environmental cultures routinely, although a growing number (about 25%) had reduced or discontinued this practice. Routine culturing was more often performed in hospitals employing passive surveillance methods. Although the adoption of selected infection control policies and practices has varied widely, chronological data indicate that a major infection control movement has emerged since 1970.

Entities:  

Mesh:

Year:  1980        PMID: 6990750     DOI: 10.1093/oxfordjournals.aje.a112935

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

1.  Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

Authors:  Valerie Aloush; Shiri Navon-Venezia; Yardena Seigman-Igra; Shaltiel Cabili; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Economical saving due to prophylaxis in the prevention of surgical wound infection.

Authors:  M Fernandez Arjona; R Herruzo Cabrera; F Gomez-Sancha; S Nieto; J Rey Calero
Journal:  Eur J Epidemiol       Date:  1996-10       Impact factor: 8.082

Review 3.  Infection Prevention in the Hospital from Past to Present: Evolving Roles and Shifting Priorities.

Authors:  Michelle Doll; Angela L Hewlett; Gonzalo Bearman
Journal:  Curr Infect Dis Rep       Date:  2016-05       Impact factor: 3.725

4.  The role of infectious disease physicians in hospital infection control.

Authors:  R W Haley
Journal:  Bull N Y Acad Med       Date:  1987 Jul-Aug

5.  Laboratory-based evaluation of MDR strains of Pseudomonas in patients with acute burn injuries.

Authors:  Hong-Tu Zhang; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 6.  Pro/con debate: Should antimicrobial stewardship programs be adopted universally in the intensive care unit?

Authors:  Philip George; Andrew M Morris
Journal:  Crit Care       Date:  2010-02-25       Impact factor: 9.097

7.  Surveillance and control of infectious diseases: progress toward the 1990 objectives.

Authors:  W R Dowdle
Journal:  Public Health Rep       Date:  1983 May-Jun       Impact factor: 2.792

8.  Surveillance of nosocomial infections by computer analysis of positive culture rates.

Authors:  R B Schifman; R A Palmer
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

9.  Computerization of a nosocomial infection system.

Authors:  S Etersque; M J Carter; K R Gordon; J G Sutherland
Journal:  J Med Syst       Date:  1984-10       Impact factor: 4.460

Review 10.  Transmission of health care-associated infections from roommates and prior room occupants: a systematic review.

Authors:  Bevin Cohen; Catherine Crawford Cohen; Borghild Løyland; Elaine L Larson
Journal:  Clin Epidemiol       Date:  2017-05-23       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.